Clinical Trial Update: Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting [NA]

View source ↗

Summary

A clinical trial comparing oral aprepitant to intravenous ondansetron for preventing postoperative nausea and vomiting has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• Ondansetron (ondansetron)

Snippet

Sponsor: Northwell Health | Conditions: Postoperative Nausea and Vomiting | NA | Status: WITHDRAWN